FdaApplication
ANDA 215177
Identifiers
- fda_app_no: ANDA215177
Properties
| Property | Value |
|---|---|
| applicant_name | ASCENT PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2025-07-15 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESCITALOPRAM OXALATE | ESCITALOPRAM OXALATE | EQ 10MG BASE | TABLET;ORAL |
| ESCITALOPRAM OXALATE | ESCITALOPRAM OXALATE | EQ 20MG BASE | TABLET;ORAL |
| ESCITALOPRAM OXALATE | ESCITALOPRAM OXALATE | EQ 5MG BASE | TABLET;ORAL |
3 products